Literature DB >> 18081817

Grading of serous ovarian carcinoma: further evidence of a lack of agreement between conventional grading systems.

N Singh, A Ayhan, U Menon, J A Chin Aleong, A Z Faruqi, S A Gayther, I J Jacobs.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18081817     DOI： 10.1111/j.1365-2559.2007.02912.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  4 in total

Review 1.  [Histological grading of epithelial ovarian cancer. Review and recommendation].

Authors:  S Hauptmann; A du Bois; I Meinhold-Herlein; J Pfisterer; S Avril
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

2.  Histological grading in a large series of advanced stage ovarian carcinomas by three widely used grading systems: consistent lack of prognostic significance. A translational research subprotocol of a prospective randomized phase III study (AGO-OVAR 3 protocol).

Authors:  Stefan Kommoss; Dietmar Schmidt; Friedrich Kommoss; Juergen Hedderich; Philipp Harter; Jacobus Pfisterer; Andreas du Bois
Journal:  Virchows Arch       Date:  2009-01-27       Impact factor: 4.064

3.  Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma.

Authors:  Ingiridur Skirnisdottir; Tomas Seidal; Helena Åkerud
Journal:  Int J Gynecol Cancer       Date:  2015-09       Impact factor: 3.437

4.  EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.

Authors:  Xiao Chen; Xuan Wang; Xue Wei; Jiandong Wang
Journal:  J Ovarian Res       Date:  2016-11-25       Impact factor: 4.234
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.